LIGAND PHARMACEUTICALS INCORPORATED: accounts_receivable
| Value | {"amount": 39506000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2020-03-31) |
| Status | current |
| Entity | LIGAND PHARMACEUTICALS INCORPORATED |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:53:36.541691+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/8b0f8bc8-9d3b-4302-92d2-bea2fc964c70
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000886163-20-000061Retrieved: 2026-08-19T08:53:36.541691+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000886163/accounts-receivable/2020-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/8b0f8bc8-9d3b-4302-92d2-bea2fc964c70
History
- no predecessors — first report